US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Progyny, Inc. - Common Stock (NQ:PGNY)

28.13 -0.84 (-2.90%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider care 
From Progyny, Inc.
Via GlobeNewswire
News headline image
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
From Progyny, Inc.
Via GlobeNewswire
News headline image
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after investors rotated into defensive assets and priced in rising expectations that midter... 
Via StockStory
Topics Bonds Government
News headline image
3 Value Stocks Walking a Fine Line
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
Progyny (NASDAQ:PGNY): A Quality Investing Watchlist Candidate ↗
Via Chartmill
Progyny (NASDAQ:PGNY): An Affordable Growth Stock With Strong Earnings and Reasonable Valuation ↗
Via Chartmill
Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals ↗
Via Chartmill
News headline image
Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting
From Progyny, Inc.
Via GlobeNewswire
News headline image
Why Are Progyny (PGNY) Shares Soaring Today
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 6% in the afternoon session after the company announced that its annual sell... 
Via StockStory
News headline image
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
From Progyny, Inc.
Via GlobeNewswire
News headline image
3 Profitable Stocks with Warning Signs
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
Topics Artificial Intelligence
Progyny (NASDAQ:PGNY) Shares Slide After Q2 Beat Overshadowed by Weak Guidance ↗
Via Chartmill
Progyny (NASDAQ:PGNY): An Affordable Growth Play With Double-Digit Earnings Expansion ↗
Via Chartmill
Progyny (PGNY): Strong Growth with Technical Setup Quality ↗
Via Chartmill
News headline image
Spotting Winners: Progyny (NASDAQ:PGNY) And Health Insurance Providers Stocks In Q2
Let’s dig into the relative performance of Progyny (NASDAQ:PGNY) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
1 Russell 2000 Stock to Consider Right Now and 2 That Underwhelm
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook ↗
Progyny (NASDAQ:PGNY) CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client... 
Via MarketBeat
News headline image
Progyny (PGNY) Q2 2026 Earnings Call Transcript ↗
Record revenue and gross profit as client count climbs to 604 and member base expands. 
Via The Motley Fool
Topics Earnings
News headline image
The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call
Progyny’s second quarter results were met with a negative market reaction, despite the company delivering revenue and non-GAAP profit above Wall Street expec... 
Via StockStory
Topics Earnings
News headline image
2 Cash-Heavy Stocks on Our Watchlist and 1 We Avoid
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o... 
Via StockStory
News headline image
Why Progyny (PGNY) Shares Are Sliding Today
What Happened? Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 4.5% in the afternoon session after the company issued a weak forecast, oversh... 
Via StockStory
News headline image
Why Progyny Stock Plunged, Then Gradually Recovered Today ↗
Progyny stock initially plummeted this morning but has steadily marched back toward even. 
Via The Motley Fool
News headline image
Progyny Q2 Earnings Call Highlights ↗
Progyny (NASDAQ:PGNY) reported record quarterly revenue, gross profit and adjusted EBITDA for the second quarter of 2026, while management said early sales commitments and client-retention activity... 
Via MarketBeat
Topics Earnings
News headline image
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 5.3% year on year to $3... 
Via StockStory
News headline image
Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2%
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 5.3% year on year to $35... 
Via StockStory
News headline image
Progyny, Inc. Announces Second Quarter 2026 Results
From Progyny, Inc.
Via GlobeNewswire
News headline image
What To Expect From Progyny’s (PGNY) Q2 Earnings
Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know. Progyny ... 
Via StockStory
News headline image
Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
From Progyny, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >